BRISTOL MYERS SQUIBB : ALLY-1 Trial Results Show Investigational Daclatasvir-Based Regimen Cures 94% of Post-Liver Transplant Patients with Hepatitis C and Up to 94% of...

Press/Media: Press / Media

PeriodMay 6 2015

Media coverage

1

Media coverage

  • TitleBRISTOL MYERS SQUIBB : ALLY-1 Trial Results Show Investigational Daclatasvir-Based Regimen Cures 94% of Post-Liver Transplant Patients with Hepatitis C and Up to 94% of...
    Media name/outlet4 Traders
    CountryUnited States
    Date5/6/15
    PersonsFred Poordad